SpyBiotech receives more than $4 million to develop vaccine platform
UK-based SpyBiotech has received a grant of more than $4 million from the Bill &…
March 20, 2023 - 2 minutes
News and Trends
67% five-year survival rate in glioblastoma therapy, according to CANbridge Pharmaceuticals study
CANbridge Pharmaceuticals Inc. has announced that its therapy for glioblastoma has shown a 67% survival…
March 17, 2023 - 3 minutes
Likang gets trial ok for China’s first personalized cancer vaccine
Likang Life Sciences has received implied approval for the clinical trial of its personalized neoantigen-targeted…
March 17, 2023 - 3 minutes
Purple Biotech sees positive results from cancer study
Purple Biotech Ltd. has released new results from exploratory analyses conducted as part of a…
March 17, 2023 - 3 minutes
Beyond Biotech podcast 38: Hello Tomorrow Global Summit
The Hello Tomorrow Global Summit took place in Paris last week (March 8-10), and we…
March 17, 2023 - 3 minutes
How cancer cells repair DNA damage from radiotherapy
A team of scientists led by Kei-ichi Takata from the Center for Genomic Integrity (CGI)…
March 17, 2023 - 5 minutes
Inspire Biotherapeutics launches to target lung diseases through gene therapy
Inspire Biotherapeutics Inc., an emerging Canadian biotech company with a mission to create gene therapies…
March 16, 2023 - 2 minutes
Mediar Therapeutics boosts fibrosis portfolio with $105M financing
Mediar Therapeutics Inc., a biotechnology company advancing a portfolio of first-in-class therapies that halt and…
March 16, 2023 - 3 minutes
Nanite receives funding to deliver genetic therapies to the lungs
Nanite Inc. has announced an investment from the Cystic Fibrosis Foundation of up to $2…
March 15, 2023 - 2 minutes
Cambrian Bio to boost aging pipeline with Amplifier Therapeutics launch
Cambrian Bio, a clinical-stage biotechnology company focused on treating and preventing chronic diseases of aging,…
March 15, 2023 - 2 minutes
Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline
Pfizer Inc. is set to acquire Seagen Inc. for $229 in cash per Seagen share…
March 14, 2023 - 6 minutes
Astellas menopause study meets endpoints but leukemia drug disappoints
There was good and bad news this week from Japanese company Astellas Pharma Inc. as…
March 14, 2023 - 4 minutes
